|
Market Cap (17-May) $95,239,352 (971st) |
Close (9-Dec) $1.04 |
Volume (9-Dec) 0 |
Shortsold (3-Dec) 50,000 (0.05%) (513th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.144 |
BD1 released this announcement to the ASX on 21 July 2021, 8:27. The announcement is marked as price sensitive, and is 2 page(s) in length and 384.71kb in size.
You can view all announcements from BD1 and see how they appear on a price chart on the announcements page.
At the date of this announcement, BD1 was 0.090% short sold according to ASIC data. It was ranked the 471st most shorted stock on the ASX. It remains ranked 513th as of the latest reported data (03 December 2021).
| Other Recent Announcements from BD1 | |
|---|---|
| BARD1 Changes its Name to INOVIQ | 8 December 2021, 8:58 |
| Cleansing Notice - Issued of Four Shares - Resolution 5 AGM | 7 December 2021, 12:12 |
| Application for quotation of securities - BD1 | 7 December 2021, 12:06 |
| Trading Halt | 21 July 2021, 8:27 |
| BARD1 Investor Presentation | 7 July 2021, 9:46 |
| BARD1 Autoantibody Test Results for Ovarian Cancer Published | 29 June 2021, 8:21 |
| SubB2M Breast Cancer Test Manuscript Submitted | 25 June 2021, 8:22 |
You must be logged in to post a reply.
BARD1 Life Sciences 